MedCity News

DECEMBER 4, 2022

Going into 2023, investors think the abilities to demonstrate ROI and clinical validation will be the most important factors determining digital health companies’ success, according to a new report. While the ROI factor is a given, clinical validation “is the best signal of patient value and historically has been under-captured in digital health,” said Sunny Kumar, a partner at GSR Ventures.

Patients 107

Patients 107

pharmaphorum

DECEMBER 4, 2022

Clinical trials of a wireless brain chip developed by Elon Muck’s Neuralink company will be tested in human volunteers within the next six months – and Musk himself says he intends to have one implanted for a future demo event. Neuralink has been promising that the technology will be ready for clinical trials soon for some time – first saying they were around the corner back in 2019 – so the latest announcement by Musk at an update last week may be met with some scepticism.

Side effects 99

Side effects Recruitment Physicians Food 99

MedCity News

DECEMBER 4, 2022

The program aims to improve work environments for nurses and remove the stigma associated with asking for mental health care. The curriculum will focus on ways to identify and reduce stress before it escalates. While it will help all nurses, the program is especially geared toward nurses of color and those under the age of 35.

93

93

pharmaphorum

DECEMBER 4, 2022

Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry. However, both industries share a common problem: failure to provide women with C-suite opportunities. In fact, women hold only 11% of executive positions at Silicon Valley companies. The biopharma industry is worse, with women only accounting for 8% of CEO roles.

Pharma 98

Pharma Management Education Leads 98

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

MedCity News

DECEMBER 4, 2022

Companies who do all the right things along the path to FDA approval while simultaneously doing all the right things for a hospital Value Analysis Committee’s approval are the companies that help hospitals avoid expensive and harmful “never events.”.

FDA 93

FDA 93

Pharma Pathway

DECEMBER 4, 2022

Lincoln Pharmaceuticals Ltd-Walk-In Interviews for Quality Control On 11th Dec’ 2022. Job Description. Walk-In Interviews for Quality Control On 11th Dec’ 2022 @ Lincoln Pharmaceuticals Ltd. Department: Quality Control. Qualification: B.Sc/ M.Sc. Experience: 01 to 06 years. Job Location: Ahmedabad. Date: Walk-In Interview On 11th Dec’ 2022.

Pharmaceutical 87

Pharmaceutical Pharma 87

Pharma Pathway

DECEMBER 4, 2022

Indoco Remedies Ltd.-Walk-In Interviews for Production/ Quality Assurance / Quality Control/ Packing On 12th & 13th Dec’ 2022. Job Description. Indoco Remedies Ltd.-Walk-In Interviews for Production/ Quality Assurance / Quality Control/ Packing On 12th & 13th Dec’ 2022 @ Indoco Remedies Ltd. Company Name: Indoco Remedies Ltd. Department: Production/ Quality Assurance (AQA)/ Quality Control/ Packing.

Pharma 86

Pharma 86

pharmaphorum

DECEMBER 4, 2022

Amgen and Sanofi have said they may make cash-only offers for Horizon Therapeutics, which confirmed it was in talks with potential buyers last week, but Johnson & Johnson has ruled itself out of the running. Under Ireland’s financial regulations Amgen and Sanofi are required to acknowledge they are considering an offer – both stressing that none may arise – while J&J has to confirm it is not considering a bid for the business at the moment.

Sales 86

Sales Biopharma Marketing 86

Pharma Pathway

DECEMBER 4, 2022

Teva Pharmaceuticals-Walk -In Interview for Regulatory Affairs On 10th Dec’ 2022. Job Description. Walk -In Interview for Regulatory Affairs On 10th Dec’ 2022 @ Teva Pharmaceuticals. Company Name: Teva Pharmaceuticals. Department: Regulatory Affairs. Positions: Associate. Qualification: Degree in Science/ Life Science/ Pharmacy. Experience: 01 to 06 years.

Pharmaceutical 81

Pharmaceutical Pharma 81

pharmaphorum

DECEMBER 4, 2022

Amgen is lagging behind rivals like Novo Nordisk and Eli Lilly with its new-generation therapy for obesity, but is sufficiently encouraged by early-stage clinical data to kick off a phase 2 programme for the drug next year. AMG 133 is a bispecific molecule that addresses two targets, GLP-1 and GIPR, and in a phase 1 study achieved clinically significant body weight reductions over 12 weeks in people with obesity and without diabetes, according to Amgen.

Manufacturing 79

Manufacturing FDA Sales Marketing 79

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharma Pathway

DECEMBER 4, 2022

Micro Labs-Walk-In Interview for Freshers & Experienced in Production/ Planning On 6th Dec’ 2022. Job Description. Greetings from Micro Labs, Goa!!! Walk-In Interview for Freshers & Experienced in Production/ Planning On 6th Dec’ 2022 @ Micro Labs. Department: Production/ Planning. Skill Set: Good working proficiency in MS office, Analytical thinking & Preparation of MIS Reports.

Pharmaceutical 77

Pharmaceutical Pharma 77

PharmaTech

DECEMBER 4, 2022

To ensure optimal processes, catalyst design is of paramount importance. This white paper will cover the various elements that are critical to consider when selecting a PGM heterogeneous catalyst for your process.

40

40

Pharma Pathway

DECEMBER 4, 2022

Neuland Laboratories Pvt. Ltd-Walk-In Interview for Plant Engineering/ Quality Control / Quality Assurance 6th & 7th Dec’ 2022. Job Description. We are hiring for different positions in Neuland at Unit-3 Gaddapotharam, Hyderabad. Walk-In Interview for Plant Engineering/ Quality Control / Quality Assurance 6th & 7th Dec’ 2022 @ Neuland Laboratories Pvt.

Engineering 85

Engineering Pharma 85

PharmaTech

DECEMBER 4, 2022

Traditionally, Oncology trials placed a heavy burden on patients due to travel burden, poor patient experience and multi-year clinical trial commitments. Sites also struggle with cancer trials due to enrollment delays, complex data workflows, and multiple amendments requiring re-consents. Today, we have a more effective, patient-first solution. Optimize patient choice, improve retention and safety with Patient- First Oncology solutions that meet patients where they are.

Patients 40

Patients Safety 40

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

Pharma Pathway

DECEMBER 4, 2022

Aurobindo Pharma-Openings for Freshers – Project Management -Apply Now. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations. Greetings from Aurobindo !!!

Management 59

Management Pharma Pharmaceutical manufacturing Manufacturing 59

Pharmacy Times

DECEMBER 4, 2022

Scott Soefje, director of Pharmacy Cancer Care and assistant professor of Pharmacy at Mayo Clinic, discusses PD-1 inhibitors and its use in non–small cell lung cancer.

26

26

Pharmaceutical Technology

DECEMBER 4, 2022

Starting in January, multiple biosimilars of AbbVie’s blockbuster drug Humira are set to flood the US pharmaceutical market. The arrival of Humira biosimilars is expected to provide cost-effective alternatives to the anti-tumor necrosis factor (TNF) biologic, but their eventual position on the market remains to be seen. Moreover, Humira’s behemoth status makes their introduction in the US particularly interesting.

Marketing 104

Marketing Physicians Competition Patients 104